<!DOCTYPE html>
<html lang="en">
    <head>
        <meta charset="UTF-8">
        <title>The site of Ariel Rechtman</title>
    </head>

    <body>
        <table cellspacing="20">
            <tr>
                <td><img src="images/Ariel_Picture.jpeg" alt="Ariel picture" width="300" height="300"></td>
                <td> <h1> Ariel Rechtman-Genzer</h1>
                    <p> <em> PhD Student in the <strong>Hebrew University of Jerusalem</strong> </em></p>
                    <p>My research focuses on Demyelinating disorders of the CNS</p></td>
            </tr>
        </table>
        <hr>
        <h3>Publications</h3>
        <ul style="line-height:1.4;">
            <li>Haramati A*, <strong> Rechtman A*</strong>, Zveik O, Haham N, Brill L, Vaknin-Dembinsky A. (2022). IL-6 as a marker for NMOSD disease activity. 
                <br>
                <u>Journal of Neuroimmunology</u>. 370:577925. 
               <strong>*Contributed equally and share the first authorship</strong> 
               <br>
               <a href="https://pubmed.ncbi.nlm.nih.gov/35810527/"> 10.1016/j.jneuroim.2022.577925 </a> 
            </li>
            <li>Zveik O, <strong>Rechtman A</strong>, Haham N, Adini I, Canello T, Lavon I, Brill L, Vaknin-Dembinsky A. (2022) Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes.
                <br>
                <u> International Journal of Molecular Sciences.</u> 23(13):7117. 
               <br>
               <a href="https://pubmed.ncbi.nlm.nih.gov/35806122/"> 10.3390/ijms23137117 </a> 
            </li>
            <li>Brill L*, <strong>Rechtman A*</strong>, Shifrin A , Rozenberg A, Afanasiev S, Zveik O, Haham N, Levin N, Vaknin-Dembinsky A. (2022) Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine.
                <u> Multiple Sclerosis and Related Disorders.</u> 63:103863. 
               <strong>*Contributed equally and share the first authorship</strong> 
               <br>
               <a href="https://pubmed.ncbi.nlm.nih.gov/35667316/"> https://doi.org/10.1016/j.msard.2022.103863 </a> 
            </li>
            <li>Zveik O, Fainstein N, <strong>Rechtman A</strong>, Haham N, Ganz T, Brill L, Vaknin-Dembinsky A. (2022) Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells. 
                <u> Glia.</u> 70(6):1191-1209. 
               <br>
               <a href="https://pubmed.ncbi.nlm.nih.gov/35266197/"> 10.1002/glia.24165 </a> 
            </li>
            <li>Brill L, Raposo C, <strong>Rechtman A</strong>, Zveik O, Levin N, Oiknine-Djian E, Wolf D, Vaknin-Dembinsky A. (2022) Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab.
                <u> Annals of Neurology.</u> 91(6):796-800. 
                <br>
               <a href="https://pubmed.ncbi.nlm.nih.gov/35243687/"> 10.1002/ana.26343 </a> 
            </li>
            <li><strong>Rechtman A</strong>, Brill L, Zveik O, Uliel B, Haham N, Bick A, Levin N, Vaknin-dembinsky A. (2022) Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course. 
                <br>
                <u> Frontiers in Neurology.</u> 13(March):1-11.  
                <br>
               <a href="https://pubmed.ncbi.nlm.nih.gov/35401390/"> 10.3389/fneur.2022.867190 </a> 
            </li>
            <li>Brill L*, <strong>Rechtman A*</strong>, Shifrin A, Rozenberg A, Afanasiev S, Zveik O, Haham N, Levin N C, Vaknin-Dembinsky A. (2022) Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis. 
                <br>
                <u>Multiple Sclerosis and Related Disorders.</u> 57:103343 
               <strong>*Contributed equally and share the first authorship</strong> 
               <br>
               <a href="https://pubmed.ncbi.nlm.nih.gov/35158452/"> 10.1016/j.msard.2021.103343 </a> 
            </li>
            <li>Brill L, <strong>Rechtman A*</strong>, Zveik O, Haham N, Oiknine-Djian E, Wolf D, Levin N, Raposo C, Vaknin-Dembinsky A. (2022) Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab.
                <u> JAMA Neurology.</u> 78(12):1510-1514.  
                <br>
               <a href="https://pubmed.ncbi.nlm.nih.gov/34554197/"> 10.1001/jamaneurol.2021.3599 </a> 
            </li>
        </ul>
        <hr>
        <a href="Conferences.html"> Conferences </a> 
        <hr>
        <h3>Honors, awards and scholarships</h3>
        <table cellspacing="10">
            <tr>
                <td>2022</td>
                <td><strong>Dean's List</strong> of outstanding M.Sc students (fifth place), Faculty of 
                    Medicine, The Hebrew University of Jerusalem
                </td>
            </tr>
            <tr>
                <td>2021</td>
                <td><strong>Abstract Grant for young researcher</strong>, International ECTRIMS 2021    
                    congress
                </td>
            </tr>
        </table>
        <hr>
        <a href="Contact_Me.html"> Contact me </a> 
    </body>
</html>
   
 